Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-125 |
Sentence |
denotes |
Host miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by upregulating type I interferons |
T2 |
127-135 |
Sentence |
denotes |
Abstract |
T3 |
136-336 |
Sentence |
denotes |
MicroRNAs (miRNAs) play important roles in viral infections, especially by modulating the expression of cellular factors essential to viral replication or the host innate immune response to infection. |
T4 |
337-553 |
Sentence |
denotes |
To identify host miRNAs important to controlling porcine reproductive and respiratory syndrome virus (PRRSV) infection, we screened 15 miRNAs that were previously implicated in innate immunity or antiviral functions. |
T5 |
554-707 |
Sentence |
denotes |
Over-expression of the miR-26 family strongly inhibited PRRSV replication in vitro, as shown by virus titer assays, Western blotting, and qRT-PCR assays. |
T6 |
708-782 |
Sentence |
denotes |
MiR-26a inhibited the replication of both type 1 and type 2 PRRSV strains. |
T7 |
783-840 |
Sentence |
denotes |
Mutating the seed region of miR-26 restored viral titers. |
T8 |
841-1046 |
Sentence |
denotes |
Luciferase reporters showed that miR-26a does not target the PRRSV genome directly but instead affects the expression of type I interferon and the IFN-stimulated genes MX1 and ISG15 during PRRSV infection. |
T9 |
1047-1246 |
Sentence |
denotes |
These results demonstrate the important role of miR-26a in modulating PRRSV infection and also support the possibility of using host miR-26a to achieve RNAi-mediated antiviral therapeutic strategies. |
T10 |
1248-1539 |
Sentence |
denotes |
MicroRNAs (miRNAs) are small (∼22 nucleotides) non-coding RNAs that bind to complementary sequences in the untranslated regions of target mRNAs and contribute to gene regulation by reducing mRNA translation or destabilizing transcripts (Grassmann and Jeang, 2008; Skalsky and Cullen, 2010) . |
T11 |
1540-1838 |
Sentence |
denotes |
The commonly accepted mechanism of miRNA regulation is that the seed region (2 ∼ 8 nucleotides at the 5 end) of an miRNA is complementary to the 5 or 3 untranslated region (5 -or 3 -UTR) of an mRNA, leading to mRNA degradation or translational inhibition (Bartel, 2009; Gottwein and Cullen, 2008) . |
T12 |
1839-2007 |
Sentence |
denotes |
Recent work has shown the importance of miRNAs in regulating host-pathogen interactions and innate immunity (Lodish et al., 2008; Scaria et al., 2007; tenOever, 2013) . |
T13 |
2008-2237 |
Sentence |
denotes |
Host miRNAs can affect viral replication by binding directly to viral RNA (Lecellier et al., 2005) or by indirectly modulating host factors to provide a less permissive environment for virus replication (Triboulet et al., 2007) . |
T14 |
2238-2383 |
Sentence |
denotes |
As miRNAs are small molecules without antigenic properties, they are considered to have potential efficacy in antiviral therapeutic applications. |
T15 |
2384-2636 |
Sentence |
denotes |
For example, human miR-122 is an essential component of the biology of hepatitis C virus replication (Jopling, 2010; Jopling et al., 2005) and therapeutic blocking of miR-122 suppresses hepatitis C viremia in non-human primates (Lanford et al., 2010) . |
T16 |
2637-2836 |
Sentence |
denotes |
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a member of the arterivirus family, is the causative agent of Porcine Reproductive and Respiratory Syndrome [PRRS; (Chand et al., 2012) ]. |
T17 |
2837-3107 |
Sentence |
denotes |
Based on their genetic and antigenic differences, PRRSV strains are classified into two distinct genotypes, North American (type 2) and European (type 1), represented by the VR-2332 (Benfield et al., 1992) and Lelystad virus (LV) (Wensvoort et al., 1991) , respectively. |
T18 |
3108-3253 |
Sentence |
denotes |
These two genotypes on two different continents share only approximately 60% nucleotide sequence identity (Forsberg, 2005; Hanada et al., 2005) . |
T19 |
3254-3440 |
Sentence |
denotes |
Many strategies for controlling PRRSV transmission have been proposed but have generally shown little success, which has stimulated the search for new ways to control PRRSV transmission. |
T20 |
3441-3534 |
Sentence |
denotes |
PRRSV can escape from innate immunity and cause persistent infections (Miller et al., 2004) . |
T21 |
3535-3664 |
Sentence |
denotes |
In mammalian cells, viral infection is a potent trigger of the interferon (IFN) response (Sadler and Williams, 2008; Sen, 2001) . |
T22 |
3665-3921 |
Sentence |
denotes |
Type I interferons can initiate the activation of JAK/STAT signaling to induce the expression of hundreds of IFN-stimulated genes (ISGs), which play an important role in antiviral activities (Albina et al., 1998; Katze et al., 2002; Overend et al., 2007) . |
T23 |
3922-4032 |
Sentence |
denotes |
However, in contrast to porcine respiratory coronavirus, PRRSV is a poor IFN-inducer (Buddaert et al., 1998) . |
T24 |
4033-4253 |
Sentence |
denotes |
Many miRNAs regulate IFN production Pedersen et al., 2007) , maintain mRNA stability (Li et al., 2012) , and regulate signals downstream of IFN to modulate antiviral immunity (Wang et al., 2010; Yoshikawa et al., 2012) . |
T25 |
4254-4413 |
Sentence |
denotes |
While most miRNAs characterized to date decrease the production of IFNs (Alam and O'Neill, 2011) , a few miRNAs that upregulate type I IFNs have been reported. |
T26 |
4414-4554 |
Sentence |
denotes |
Recent research has revealed that miR-23 may play a positive modulatory role in IFN production during PRRSV infection (Zhang et al., 2014) . |
T27 |
4555-4724 |
Sentence |
denotes |
Given the breadth of miRNA-mediated regulation of mammalian immunity (Grassmann and Jeang, 2008) , the role of host miRNAs in PRRSV infection is of significant interest. |
T28 |
4725-4782 |
Sentence |
denotes |
Here, we found that miR-26a is an anti-PRRSV host factor. |
T29 |
4783-4893 |
Sentence |
denotes |
Over-expression of miR-26a inhibited infection by both of the major PRRSV genotypes in a dosedependent manner. |
T30 |
4894-5080 |
Sentence |
denotes |
We found that miR-26a does not target the PRRSV genome directly, but rather affects the expression of type I interferon and the IFN-stimulated genes MX1 and ISG15 during PRRSV infection. |
T31 |
5081-5244 |
Sentence |
denotes |
Our study reveals an example of a miRNA that affects viral propagation and highlights a host factor that may be important for future control measures against PRRS. |
T32 |
5245-5482 |
Sentence |
denotes |
MARC-145 cells were grown in MEM (Invitrogen) with 10% fetal bovine serum (FBS, Gibco-BRL, Gaithersburg, MD, USA) and were maintained with 2% FBS at 37 • C in a humidified 5% CO 2 atmosphere as described previously (Yuan and Wei, 2008) . |
T33 |
5483-5604 |
Sentence |
denotes |
Baby hamster kidney (BHK-21, ATCC CCL10) cells were cultured in EMEM (ATCC, Manassas, VA, USA) supplemented with 10% FBS. |
T34 |
5605-5880 |
Sentence |
denotes |
Porcine alveolar macrophages (PAMs) were harvested from the lungs of 6-week-old PRRSV-negative piglets as described previously (Wensvoort et al., 1991) and maintained at 37 • C in RPMI 1640 (Gibco) supplemented with 10% fetal bovine serum (FBS). vAPRRS (GenBank accession No. |
T35 |
5881-5943 |
Sentence |
denotes |
GQ330474) (Yuan and Wei, 2008) and vSHE (GenBank accession No. |
T36 |
5944-6197 |
Sentence |
denotes |
GQ461593) (Tian et al., 2011) were rescued from pAPRRS and pSHE, respectively. vJX143 (at passage 3) was isolated from the serum of a dying piglet displaying the clinical sings of porcine high fever disease (PHFD) in 2006. vJXM100 (GenBank accession No. |
T37 |
6198-6344 |
Sentence |
denotes |
GQ475526) was obtained through 100 serial passages of the highly pathogenic PRRSV vJX143 strain (EU708726) in MARC-145 cells (Wang et al., 2013) . |
T38 |
6345-6421 |
Sentence |
denotes |
The infectious cDNA clone pJX143 was derived from vJX143 (Lv et al., 2008) . |
T39 |
6422-6530 |
Sentence |
denotes |
High-titer virus stocks were obtained by infecting MARC-145 cells at low multiplicities of infection (MOIs). |
T40 |
6531-6686 |
Sentence |
denotes |
Infected cell supernatants were harvested after an 80% cytopathic effect (CPE) appeared, then the viruses were stored at −80 • C as stocks for further use. |
T41 |
6687-6761 |
Sentence |
denotes |
Virus titer was determined by standard TCID 50 assay using MARC-145 cells. |
T42 |
6762-6950 |
Sentence |
denotes |
miRNA mimics (Table 1) , which are double-stranded 2 -Omethyl-modified RNA oligonucleotides with sequence complementarity to mature miRNAs were synthesized by GenePharma (Shanghai, China). |
T43 |
6951-7257 |
Sentence |
denotes |
The sense sequences of the miR-26 mimics were: miR-26a-5 -uucaaguaauccaggauaggcu-3 ; miR-26b-5 -uucaaguaauucaggauaggu-3 ; corresponding non-seed-mutated miR-26 mimics (26-1A, 26-9U, and 26-1A9U) or seed-mutated miR-26 mimics (26a-m, 26b-m, c-m) are listed in Table 1 (underlined letters are mutated bases). |
T44 |
7258-7331 |
Sentence |
denotes |
The negative-control (NC) mimic sequence was 5 -uucuccgaacgugucacgutt-3 . |
T45 |
7332-7336 |
Sentence |
denotes |
2.3. |
T46 |
7337-7587 |
Sentence |
denotes |
Transfection of miRNA mimic and viral multi-step growth kinetics miRNA or NC mimics were transfected into PAMs or MARC-145 cells at a concentration of 80 nM (except for dosedependence experiments) using X-tremeGENE siRNA Transfection Reagent (Roche). |
T47 |
7588-7657 |
Sentence |
denotes |
Twenty-four hours after transfection, cells were infected with PRRSV. |
T48 |
7658-7811 |
Sentence |
denotes |
For analysis of PRRSV growth, supernatants (0.2 ml/well) from cell cultures were collected at different time points post-infection and frozen at −80 • C. |
T49 |
7812-7989 |
Sentence |
denotes |
For virus quantification at each time point, a viral titer was measured in MARC-145 cells by standard TCID 50 assay using the method of Reed and Muench (Reed and Muench, 1938) . |
T50 |
7990-8236 |
Sentence |
denotes |
Indirect immunofluorescence assays (IFA) were performed as described previously (Tian et al., 2011) for the detection of nucleocapsid (N) protein in PRRSV vJX143 infected MARC-145 cells or PAMs pre-transfected with miR-26 family or mutant mimics. |
T51 |
8237-8464 |
Sentence |
denotes |
Cells were fixed with cold methanol followed by blocking with 1% bovine serum albumin (BSA) and then incubated for 2 h with a monoclonal antibody (SR30A, Rural Technologies) that specifically recognizes type 2 PRRSV N proteins. |
T52 |
8465-8627 |
Sentence |
denotes |
After washing with phosphate-buffered saline (PBS), the cells were incubated for 1 h with Alexa Fluor 568-labeled goat anti-mouse secondary antibody (Invitrogen). |
T53 |
8628-8723 |
Sentence |
denotes |
Cell nuclei were counterstained with 1 g/ml of 4 , 6 -diamidino-2phenylindole (DAPI) for 5 min. |
T54 |
8724-8832 |
Sentence |
denotes |
After a final PBS wash step, cells were visually analyzed using an Olympus inverted fluorescence microscope. |
T55 |
8833-8916 |
Sentence |
denotes |
MARC-145 cells were transfected with miR-26a or NC mimics prior to PRRSV infection. |
T56 |
8917-9048 |
Sentence |
denotes |
Cells were washed twice with PBS at 48 h post-infection and lysed with lysis buffer in the presence of 1 mM N-ethylmaleimide (NEM). |
T57 |
9049-9185 |
Sentence |
denotes |
After incubation for 10 min on ice, cell lysates were centrifuged at 12,000 × g for 15 min at 4 • C and the supernatants were collected. |
T58 |
9186-9325 |
Sentence |
denotes |
Protein samples were prepared in reducing buffer (50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 0.02% [wt./vol.] bromophenol blue, 100 mM DTT). |
T59 |
9326-9473 |
Sentence |
denotes |
Samples then were heated at 95 • C for 5 min, resolved on 15% SDS polyacrylamide gels, and transferred to Hybond-Pmembranes (Amersham Biosciences). |
T60 |
9474-9606 |
Sentence |
denotes |
Membranes were blocked with 5% nonfat dry milk in TBST (100 mM NaCl, 10 mM Tris, pH 7.6, 0.1% Tween 20) for 2 h at room temperature. |
T61 |
9607-9799 |
Sentence |
denotes |
Membranes were incubated overnight at 4 • C with primary antibody (1AG11) that specifically recognizes both type 2 and type 1 PRRSV N proteins (kindly provided by Ingenasa Co., Madrid, Spain). |
T62 |
9800-10141 |
Sentence |
denotes |
After washing with TBST, blots were incubated with horseradish peroxidase (HRP)conjugated goat anti-mouse secondary antibody (Santa Cruz) for 1 h at room temperature, washed again with TBST, and developed using SuperSignal West Pico or Femto chemiluminescent substrate according to the manufacturer's instructions (Thermo Fisher Scientific). |
T63 |
10142-10244 |
Sentence |
denotes |
Total RNA and miRNA were extracted with TRIzol (Invitrogen) following the manufacturer's instructions. |
T64 |
10245-10334 |
Sentence |
denotes |
PrimeScript TM 1st Strand cDNA Synthesis Kit (Takara) was used for reverse transcription. |
T65 |
10335-10486 |
Sentence |
denotes |
Quantitative RT-PCR (qPCR) analysis was performed using a Step-one Plus real-time PCR system (Applied Biosystems) and a SYBR Premix Ex Taq TM (Takara). |
T66 |
10487-10685 |
Sentence |
denotes |
For detection of endogenous miRNAs, a commercial miRcute miRNA First-Strand cDNA Synthesis was purchased from TIANGEN BIOTECH (Beijing, China) and used for polyadenylation and reverse transcription. |
T67 |
10686-10814 |
Sentence |
denotes |
A commercial miRcute miRNA qPCR detection kit was purchased from TIANGEN BIOTECH (Beijing, China) for measuring miRNA abundance. |
T68 |
10815-10973 |
Sentence |
denotes |
MARC-145 cells infected with PRRSV at a MOI of 0.01 were collected at the indicated time points and total RNA was extracted using TRIzol reagent (Invitrogen). |
T69 |
10974-11056 |
Sentence |
denotes |
One g of this total RNA was then used for reverse transcription with an RT-primer. |
T70 |
11057-11210 |
Sentence |
denotes |
The abundance of the miRNA of interest in the resulting cDNA was determined by qPCR using a universal reverse primer and a miRNA-specific forward primer. |
T71 |
11211-11327 |
Sentence |
denotes |
The PCR procedure comprised pre-denaturation at 94 • C for 2 min, and 40 cycles of 94 • C for 20 s, 60 • C for 15 s. |
T72 |
11328-11421 |
Sentence |
denotes |
The ubiquitously expressed U6 small nuclear RNA (TIANGEN) was used for normalization purpose. |
T73 |
11422-11490 |
Sentence |
denotes |
All primers used for miRNA qPCR were included in the commercial kit. |
T74 |
11491-11595 |
Sentence |
denotes |
The levels of ORF7 RNA, IFN-␣/, MX1, ISG15 mRNA were quantified using a SYBR Premix Ex Taq TM (Takara). |
T75 |
11596-11774 |
Sentence |
denotes |
Relative expression levels were analyzed using the Ct method (Bookout et al., 2006) , and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as an endogenous control. |
T76 |
11775-11843 |
Sentence |
denotes |
Universal type I interferon was purchased from PBL InterferonSource. |
T77 |
11844-11893 |
Sentence |
denotes |
All PCR experiments were performed in triplicate. |
T78 |
11894-11931 |
Sentence |
denotes |
Other primers are listed in Table 2 . |
T79 |
11932-12103 |
Sentence |
denotes |
The pGL3-Control luciferase reporter vector (Promega) was used as the cloning vector for luciferase assays to analyze potential miR-26a target regions in the PRRSV genome. |
T80 |
12104-12272 |
Sentence |
denotes |
Twenty cDNA fragments encompassing the PRRSV genome were amplified by PCR from PRRSV pJX143 and subcloned into the pGL3-Control vector downstream of the luciferase ORF. |
T81 |
12273-12364 |
Sentence |
denotes |
The primers used are listed Table 2 Sequence of oligonucleotide primers used in this study. |
T82 |
12365-12383 |
Sentence |
denotes |
Sequence Table 2 . |
T83 |
12384-12436 |
Sentence |
denotes |
All cDNA constructs were verified by DNA sequencing. |
T84 |
12437-12570 |
Sentence |
denotes |
Plasmids and miRNA mimics were transfected into cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer s protocol. |
T85 |
12571-12874 |
Sentence |
denotes |
For luciferase reporter assays, subconfluent BHK-21 cells cultured in 12-well plates were co-transfected with 500 ng/well of the indicated reporter plasmid and 100 ng/well of pRL-CMV (as an internal control to normalize transfection efficiency, Promega) along with the indicated amount of miR-26a mimic. |
T86 |
12875-12998 |
Sentence |
denotes |
Cells were lysed 24 h later for determination of firefly luciferase activities using the Luciferase assay system (Promega). |
T87 |
12999-13189 |
Sentence |
denotes |
Data are presented as the relative luciferase activities in miR-26a mimic-transfected cells relative to NC mimic-transfected controls and are representative of three independent experiments. |
T88 |
13191-13601 |
Sentence |
denotes |
To screen potential miRNAs for their ability to inhibit PRRSV replication, mimics of 15 miRNAs that are well-conserved among different species and have been previously implicated in innate immunity and/or antiviral functions (Banerjee et al., 2013; Foley and O'Neill, 2012; Huang et al., 2014; Yoo and Liu, 2013; Pauley and Chan, 2008; Schulte et al., 2013; Selvamani et al., 2014) were synthesized (Table 1) . |
T89 |
13602-13727 |
Sentence |
denotes |
MARC-145 cells were transfected with individual miRNA mimics (80 nM) and then infected with PRRSV (vAPRRS) at an MOI of 0.01. |
T90 |
13728-13832 |
Sentence |
denotes |
Supernatants from infected cells were collected at 24 and 48 h post-infection to determine viral titers. |
T91 |
13833-13936 |
Sentence |
denotes |
Among the miRNAs tested, over-expression of the miR-26a mimic strongly reduced PRRSV titers (Fig. 1A) . |
T92 |
13937-14155 |
Sentence |
denotes |
Transfection of miR-26a/26b inhibitors demonstrated the opposite effects (Fig. 1B) , indicating that miR-26 has antiviral activity against PRRSV replication and that miR-26a is a more efficient suppressor than miR-26b. |
T93 |
14156-14262 |
Sentence |
denotes |
All the other miRNA mimics tested had no demonstrable impact on PRRSV titers in MARC-145 cells (Fig. 1A) . |
T94 |
14263-14423 |
Sentence |
denotes |
Furthermore, immunofluorescence assays using a FITC-conjugated monoclonal antibody against the PRRSV N protein were consistent with viral titer data (Fig. 1C) . |
T95 |
14424-14705 |
Sentence |
denotes |
To rule out the possibility that this antiviral effect of miR-26a was specific to an individual PRRSV strain, we analyzed the viral growth curves of two type 2 PRRSV strains (vJX143, vJXM100) and a type 1 PRRSV strain (vSHE) in MARC-145 cells transfected with NC or miR-26a mimics. |
T96 |
14706-14853 |
Sentence |
denotes |
Over-expression of the miR-26a mimic, but not the NC mimic, reduced PRRSV replication in multiple PRRSV strains of differing genotypes ( Fig. 2A) . |
T97 |
14854-15033 |
Sentence |
denotes |
To corroborate our findings with miR-26a further, MARC-145 cells were transfected with increasing concentrations of miR-26a mimic (5, 20, 40, 80 nM) and then infected with vAPRRS. |
T98 |
15034-15162 |
Sentence |
denotes |
Both PRRSV growth and the amount of ORF7 mRNA level were inhibited as a function of the dose of miR-26a mimic ( Fig. 2B and C) . |
T99 |
15163-15322 |
Sentence |
denotes |
Consistent with this, transfecting the miR-26a mimic also reduced the accumulation of the PRRSV nucleocapsid (N) protein in a dose-dependent manner (Fig. 2D) . |
T100 |
15323-15534 |
Sentence |
denotes |
To exclude the possibility that reduced PRRSV replication was due to potential toxicity of the miR-26a mimic, MARC-145 cells were transfected with the miR-26a mimic at different doses (40 nM, 80 nM, and 160 nM). |
T101 |
15535-15663 |
Sentence |
denotes |
No appreciable effect of the miR-26a mimic (at up to 160 nM) on cellular viability and morphology was observed (data not shown). |
T102 |
15664-15788 |
Sentence |
denotes |
Collectively, these data show that miR-26a reduces PRRSV replication in multiple PRRSV genotypes in a dose-dependent manner. |
T103 |
15790-15877 |
Sentence |
denotes |
We next investigated the effect of other miR-26 miRNA and mutants on PRRSV replication. |
T104 |
15878-16046 |
Sentence |
denotes |
Because miR-26a is highly conserved between monkeys and pigs, we conducted the subsequent investigations in PAMs, which are the target cells of PRRSV infection in vivo. |
T105 |
16047-16161 |
Sentence |
denotes |
As previously reported, miRNA-mRNA interactions may require seed-matched sites at nucleotides 2-8 (Bartel, 2009 ). |
T106 |
16162-16286 |
Sentence |
denotes |
Thus, we mutated miR-26a mimic at non-seed nucleotides 1, 9, or 1 and 9 and miR-26 at seed nucleotides 2-6 (26a-m and 26bm). |
T107 |
16287-16344 |
Sentence |
denotes |
Both miR-26a and miR-26b had anti-PRRSV activity in PAMs. |
T108 |
16345-16527 |
Sentence |
denotes |
PAMs transfected with miR-26a or miR-26b mimics yielded significantly lower PRRSV titers and ORF7 gene expression compared with cells transfected with the NC mimic ( Fig. 3A and B) . |
T109 |
16528-16670 |
Sentence |
denotes |
Three miR-26a mutants with non-seed mutations retained their ability to inhibit PRRSV progeny production and gene expression ( Fig. 3A and B). |
T110 |
16671-16900 |
Sentence |
denotes |
By contrast, seed mutations at nts 2-6 abrogated the ability of miR-26 family members to repress PRRSV replication and gene expression (Fig. 3A and B) , showing that the seed region was essential for inhibiting PRRSV replication. |
T111 |
16901-17065 |
Sentence |
denotes |
To investigate further inhibition effect of miR-26 family and mutants on PRRSV infection, we used an immunofluorescence assay to detect the PRRSV N protein in PAMs. |
T112 |
17066-17268 |
Sentence |
denotes |
N protein expression in PAMs was suppressed by both miR-26a and miR-26b (Fig. 3C , top) and by miR-26 non-seed mutants (Fig. 3C, middle) , but was not affected by miR-26 seed mutants (Fig. 3C, bottom) . |
T113 |
17269-17385 |
Sentence |
denotes |
We then analyzed the growth dynamics of HP-PRRSV isolate vJX143 in PAMs transfected with miR-26 family or NC mimics. |
T114 |
17386-17548 |
Sentence |
denotes |
Viral growth was suppressed about 1000-fold in PAMs transfected with miR-26a and about 100-fold in PAMs transfected with miR-26b at 24 h postinfection (Fig. 3D) . |
T115 |
17549-17623 |
Sentence |
denotes |
Notably, miR-26a was more efficient suppressing viral growth than miR-26b. |
T116 |
17624-17815 |
Sentence |
denotes |
These results indicated that miR-26 family members, especially miR-26a, can inhibit vJX143 replication in PAMs. We then analyzed the kinetics of miR-26 expression in PRRSV infected PAM cells. |
T117 |
17816-17915 |
Sentence |
denotes |
The relative expression of miR-26 was upregulated as a function of PRRSV infection time (Fig. 3E) . |
T118 |
17916-18072 |
Sentence |
denotes |
Targeting a specific viral sequence represents an efficient strategy by which miRNAs can inhibit viral replication (Jopling, 2010; Lecellier et al., 2005) . |
T119 |
18073-18260 |
Sentence |
denotes |
In recent studies, miR-181 and miR-23 were confirmed to reduce viral gene expression and viral growth due to direct targeting of PRRSV genomic RNA (Guo et al., 2013; Zhang et al., 2014) . |
T120 |
18261-18654 |
Sentence |
denotes |
We determined whether miR-26a specifically targets the PRRSV genome to exert its antiviral effect by constructing a range of firefly luciferase reporter pGL3-Control based plasmids, which contained the cDNA fragments representing the 5 UTR, nsp1-nsp12, ORF2-ORF7, and the 3 UTR of the PRRSV genome Statistical significance was analyzed using t-tests; *, P < 0.05; **, P < 0.01; ***, P < 0.001. |
T121 |
18655-18657 |
Sentence |
denotes |
C. |
T122 |
18658-18770 |
Sentence |
denotes |
PAMs were transfected with the indicated miRNA mimics and then infected with PRRSV vJX143 (MOI = 0.01) for 24 h. |
T123 |
18771-18915 |
Sentence |
denotes |
Cells were fixed and immunostained with the mouse monoclonal SR30A antibody against the viral N protein and FITC-conjugated goat anti mouse IgG. |
T124 |
18916-18972 |
Sentence |
denotes |
Cellular nuclei were counterstained with DAPI (1 mg/ml). |
T125 |
18973-18975 |
Sentence |
denotes |
D. |
T126 |
18976-19035 |
Sentence |
denotes |
PRRSV growth in PAMs transfected with miR-26 family mimics. |
T127 |
19036-19153 |
Sentence |
denotes |
PAMs were transfected with miR-26 family or NC mimics for 24 h and then infected with PRRSV vJX143 at an MOI of 0.01. |
T128 |
19154-19226 |
Sentence |
denotes |
Culture supernatants were collected at the indicated times and titrated. |
T129 |
19227-19229 |
Sentence |
denotes |
E. |
T130 |
19230-19290 |
Sentence |
denotes |
Time-course of miR-26a/26b expression after PRRSV infection. |
T131 |
19291-19445 |
Sentence |
denotes |
PAM cells infected with vJX143 at a MOI of 0.01 were collected at the indicated times and qRT-PCR analysis was performed to detect miR-26a/26b expression. |
T132 |
19446-19627 |
Sentence |
denotes |
Relative miR-26a/b expression refers to the change in miR-26a/b expression levels in PRRSV-infected PAMs relative to mock PAMs. downstream of the firefly luciferase gene (Fig. 4A ). |
T133 |
19628-19770 |
Sentence |
denotes |
If the PRRSV cDNA insert contains a miR-26a target sequence, luciferase reporter expression is expected to be subjected to miR-26a-regulation. |
T134 |
19771-19914 |
Sentence |
denotes |
MiR-26a or NC mimics were co-transfected with the individual reporter vectors into BHK-21 cells, along with an internal control vector pRL-CMV. |
T135 |
19915-19985 |
Sentence |
denotes |
Relative luciferase activities were quantified 24 h post-transfection. |
T136 |
19986-20214 |
Sentence |
denotes |
The relative luciferase activities for different vectors containing various PRRSV cDNA fragments were not significantly different between cells transfected with miR-26a mimic as compared with cells transfected with the NC mimic. |
T137 |
20215-20281 |
Sentence |
denotes |
Thus, miR-26a does not appear to target directly the PRRSV genome. |
T138 |
20282-20455 |
Sentence |
denotes |
We found that over-expression of miR-26a increased IFN-␣/ expression during vJX143 infection (MOI = 0.01) at 36 h in PAMs as compared with over-expression of NC (Fig. 5A ). |
T139 |
20456-20542 |
Sentence |
denotes |
The IFN-stimulated genes MX1 and ISG15 were also significantly upregulated (Fig. 5B) . |
T140 |
20543-20672 |
Sentence |
denotes |
Transfecting the miR-26a mimic into PAMs in the absence of PRRSV infection also enhanced type I IFN expression ( Fig. 5A and B) . |
T141 |
20673-20802 |
Sentence |
denotes |
IFN-␣ and IFN- were induced about 1.6-fold in un-infected PAMs, and about 4.9-and 2.8-fold in PRRSV infected PAMs, respectively. |
T142 |
20803-20940 |
Sentence |
denotes |
ISG15 and MX1 were increased about 3.5-and 2.2-fold in un-infected PAMs, and about 3.6-and 2.4-fold in PRRSV infected PAMs, respectively. |
T143 |
20941-21041 |
Sentence |
denotes |
In MARC-145 cells, over-expression of miR-26a up-regulated IFN-␣ and ISG15 more strongly (Fig. 5C ). |
T144 |
21042-21200 |
Sentence |
denotes |
IFN-␣ and ISG15 were induced about 4.4-and 9.8-fold in un-infected MARC-145 cells, and about 9.1-and 20.4-fold in PRRSV infected MARC-145 cells, respectively. |
T145 |
21201-21394 |
Sentence |
denotes |
Transfection of miR-26a inhibitors did not increase the expression of IFN-␣ or ISG15 (Fig. 5C) , confirming that the induction of the innate immune response is specifically mediated by miR-26a. |
T146 |
21396-21575 |
Sentence |
denotes |
There is a growing body of evidence that cellular miRNAs are important regulators of innate and adaptive immune responses and the intricate networks of host-pathogen interactions. |
T147 |
21576-21697 |
Sentence |
denotes |
Herein, we identified miR-26a as an inhibitor of PRRSV replication that does not directly target the PRRSV genome ( Figs. |
T148 |
21698-21708 |
Sentence |
denotes |
1 and 4) . |
T149 |
21709-21954 |
Sentence |
denotes |
Overexpressed miR-26a reduced PRRSV replication and viral gene expression (Fig. 2) , in not only MARC-145 cells, but also in PAMs (Fig. 3) , the main target cell for PRRSV replication in vivo, confirming the biological relevance of this finding. |
T150 |
21955-22092 |
Sentence |
denotes |
MiR-26a belongs to a broadly conserved miRNA family with perfectly identical sequences among vertebrates (Griffiths-Jones et al., 2006) . |
T151 |
22093-22400 |
Sentence |
denotes |
Previous studies of miR-26a have shown that this miRNA is an important regulator of cell proliferation and differentiation that targets the SMAD1 transcription factor (Ezh2), a suppressor of skeletal muscle cell differentiation (Lu et al., 2011; Luzi et al., 2008; Sander et al., 2008; Zhang et al., 2011) . |
T152 |
22401-22618 |
Sentence |
denotes |
By infecting PAMs with PRRSV strain VR-2332, Liu et al. generated small RNA expression profiles at 12, 24 and 48 h post-infection to identify alterations in miRNA expression associated with PRRSV (Yoo and Liu, 2013) . |
T153 |
22619-22803 |
Sentence |
denotes |
Overall, 40 cellular miRNAs were differentially expressed during at least one time point in PRRSV-infected PAMs. However, in this study, miR-26a was not mentioned (Yoo and Liu, 2013) . |
T154 |
22804-22940 |
Sentence |
denotes |
Contrary to the previous study, we found that the expression of miR-26a was up-regulated about 2-fold at 48 h post-infection (Fig. 3E) . |
T155 |
22941-23087 |
Sentence |
denotes |
One mechanism by which host miRNAs regulate viral replication is the direct targeting of viral sequences (Jopling, 2010; Lecellier et al., 2005) . |
T156 |
23088-23270 |
Sentence |
denotes |
However, PRRSV is a fast-evolving RNA virus (Prieto et al., 2009) and the relatively high mutation rate may limit the application of this kind of RNAi-mediated antiviral therapeutic. |
T157 |
23271-23368 |
Sentence |
denotes |
Cellular miRNAs can also indirectly modulate cellular pathways that perturb the viral life cycle. |
T158 |
23369-23579 |
Sentence |
denotes |
In particular, the activation or enhancement of innate antiviral immune pathways has been suggested to be responsible for the antiviral effect of certain miRNAs (Lecellier et al., 2005; Pedersen et al., 2007) . |
T159 |
23580-23726 |
Sentence |
denotes |
In the current study, the reduction of PRRSV replication by miR-26a did not appear to involve direct targeting of the PRRSV genomic RNA (Fig. 4) . |
T160 |
23727-23899 |
Sentence |
denotes |
Moreover, this reduction occurred in both type 1 and type 2 PRRSV strains ( Fig. 2A) although these two genotypes share only approximately 60% nucleotide sequence identity. |
T161 |
23900-24005 |
Sentence |
denotes |
These data led us to hypothesize that miR-26a might act on a cellular factor to reduce PRRSV replication. |
T162 |
24006-24164 |
Sentence |
denotes |
The results presented here support a link between PRRSV replication and the altered expression of miR-26a in targeting host innate immune responses (Fig. 5) . |
T163 |
24165-24363 |
Sentence |
denotes |
Type I interferons (IFNs) are potent antiviral cytokines whose expression is triggered through recognition of viral components by pattern recognition receptors via a cascade of signaling molecules . |
T164 |
24364-24500 |
Sentence |
denotes |
PAMs are the main target cells for PRRSV infection, and many gene expression studies have explored the immune response of PAMs to PRRSV. |
T165 |
24501-24686 |
Sentence |
denotes |
Such studies have shown that the expression levels of MX1, USP, IFN-, IL-10, and TNF-␣ are affected by PRRSV infection (Albina et al., 1998; Luo et al., 2008; Van Reeth et al., 1999) . |
T166 |
24687-24879 |
Sentence |
denotes |
Overall, these analyses suggest that PRRSV subverts host defenses by inhibiting the expression of pro-inflammatory cytokines (Van Reeth et al., 1999) and stimulating weak production of IFN-␣ . |
T167 |
24880-25128 |
Sentence |
denotes |
Our results showed that over-expression of miR-26a was capable of inducing expression of IFN-␣/ and the IFN-stimulated genes ISG15 and MX1, which might result in activation of the IFN response and further lead to the inhibition of virus infection. |
T168 |
25129-25300 |
Sentence |
denotes |
The restoration of innate immune responses to produce type I IFNs in PAMs seems to be miRNA specific, because another miRNA (miR-181b) had no such effect (data not shown). |
T169 |
25301-25430 |
Sentence |
denotes |
Thus, it is possible that miR-26a-induced type I IFN expression can overcome PRRSV interference, contributing to viral clearance. |
T170 |
25431-25760 |
Sentence |
denotes |
This mechanism provides a higher genetic barrier to the emergence of viral escape mutants, so the identification and characterization of miR-26a as an inhibitor of PRRSV replication may open new ways to control Fig. 5 . miR-26a increases type I IFN expression during PRRSV infection. qRT-PCR analysis of (A. type I IFN ␣/ and B. |
T171 |
25761-25940 |
Sentence |
denotes |
MX1/ISG15) expression in PAMs transfected with NC or miR-26a mimics or left untreated (mock) for 24 h, and then infected with vJX143 for 36 h at an MOI of 0.01, or left untreated. |
T172 |
25941-26053 |
Sentence |
denotes |
Data were normalized to GAPDH expression and are the mean ± standard deviation of three independent experiments. |
T173 |
26054-26230 |
Sentence |
denotes |
C. qRT-PCR analysis of IFN-␣ and ISG15 expression in Marc-145 cells transfected with NC, miR-26a mimics or inhibitors, and then infected with vJX143 for 36 h at an MOI of 0.01. |
T174 |
26231-26274 |
Sentence |
denotes |
Data were normalized to -actin expression. |
T175 |
26275-26444 |
Sentence |
denotes |
Statistical significance was analyzed using t-tests; *, P < 0.05; **, P < 0.01; ***, P < 0.001. future PRRS outbreaks, for which effective control measures remain scant. |
T176 |
26445-26561 |
Sentence |
denotes |
Our results showed that miR-26a also can mediate the activation of IFNs in the absence of PRRSV infection (Fig. 5 ). |
T177 |
26562-26775 |
Sentence |
denotes |
The possible causes may relate to recent studies about a new function of miRNAs, which is independent of their conventional role in post-transcriptional gene regulation Fabbri et al., 2012; Lehmann et al., 2012) . |
T178 |
26776-27013 |
Sentence |
denotes |
MiR-21, miR-29a, and let-7b have dual functions; on one hand, they bind to Argonaute proteins and guide the silencing of target genes, and on the other hand, they act independently of Argonaute proteins by interacting directly with TLRs. |
T179 |
27014-27114 |
Sentence |
denotes |
Although there is no current evidence, miR-26a may also serve as ligands for TLRs and activate IFNs. |
T180 |
27115-27192 |
Sentence |
denotes |
Future studies will be necessary to unravel the diverse functions of miR-26a. |
T181 |
27193-27277 |
Sentence |
denotes |
Overall, we demonstrated that over-expression of miR-26a inhibits PRRSV replication. |
T182 |
27278-27575 |
Sentence |
denotes |
Although clearly defining the target and physiological role of miR-26a remains an unfinished task, our study provided evidence that over-expression of miR-26a enhances IFN-␣/ expression during PRRSV infection, suggesting that miR-26a could be used as a potential target for antiviral development. |